This month, FDA approval of mifepristone, a key drug used for medication abortion, has been the subject of several federal rulings. Representatives of the FDA and private drug companies have spoken out against the motion to overrule FDA approval, citing extensive safety data. Depending on the decision from the Supreme Court, these rulings could set a new precedent allowing federal courts to overturn FDA approval.
View More Abortion Pill Rulings Leave the FDA in Political Crossfire
Martin Shkreli became the internet’s most hated man in 2015 for hiking the price of life-saving medicine and mocking his online critics. Last month, Shkreli returned to the headlines when he started a new drug discovery company. As the FTC cracks down on Shkreli’s business, drug prices continue to rise.
View More Martin Shkreli Returns as Drug Prices Continue to Rise
7/6/2020 The race to develop a legitimate medication or vaccine for COVID-19 has dominated the pharmaceutical industry for the past several months as the virus…
View More Prioritizing Profit in a Pandemic
Introduction In the last century, average life expectancy in the United States increased by over three decades [1]. This was in large part due to…
View More Exorcising Research Ghosts: The Ethical Issues Associated with Medical Ghostwriting